Delisting risk
ProPhase Labs
Operator of whole-genome sequencing, esophageal diagnostics, and OTC supplement brands.
$0.0211
After-hours close0.00 (0.00%)
At close$0.0211(−0.00%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 2.13%Insiders —
Shares outstanding 14.02M · Float 13.68M · 97.6% free float
Insiders — no current Form 4 position.
Institutions13F, as of Sep 30, 2025
31 holders · 299.2K shares · 7 new positions · 14 increased · 5 reduced · 10 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Sykon Capital LLC | 64.5K | 0.46% | 0 | Nov 14, 2025 |
| Vanguard Group Inc | 53.2K | 0.38% | +12.4K | Nov 7, 2025 |
| Susquehanna International Group, LLP | 39.8K | 0.28% | +29.6K | Nov 14, 2025 |
| Geode Capital Management, LLC | 30.3K | 0.22% | +4.4K | Nov 12, 2025 |
| Accretive Wealth Partners, LLC | 25.0K | 0.18% | +25.0Knew | Nov 7, 2025 |
| Hightower Advisors, LLC | 23.7K | 0.17% | +788 | Nov 7, 2025 |
| Apollon Wealth Management, LLC | 18.2K | 0.13% | +18.2Knew | Oct 17, 2025 |
| Chapin Davis, Inc. | 8.0K | 0.06% | 0 | Oct 9, 2025 |
Beneficial owners13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
InsidersForm 4
No current Form 4 position on record.
2 ten-percent owners hold 321.0K shares by Form 4, outside the officers-and-directors figure above · 12 people have not refiled in the last 18 months (326.6K shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.